Most Clicked StoriesMore >


Dapagliflozin reduces A1C levels in patients with diabetes, CVD

DiabetesPro SmartBrief | Apr 17, 2015

Researchers looked at the efficacy of using dapagliflozin among type 2 diabetes patients with pre-existing cardiovascular disease and a history of hypertension, and found that the drug significantly decreased the patients' A1C levels at 24 weeks, compared with placebo. The findings were published in Diabetes Care. Healio (free registration) (04/16)


USPSTF review explores screening for type 2 diabetes

DiabetesPro SmartBrief | Apr 14, 2015

Diabetes in early pregnancy linked to higher autism risk in children

DiabetesPro SmartBrief | Apr 15, 2015

Standards of Medical Care in Diabetes: Abridged for Primary Care Providers – Now available

DiabetesPro SmartBrief | Apr 17, 2015

Researchers look at effect of circadian rhythm on blood glucose

DiabetesPro SmartBrief | Apr 14, 2015

Diabetes is Primary – CME Program

DiabetesPro SmartBrief | Apr 14, 2015

Study shows metabolism changes after 5-day high-fat diet

DiabetesPro SmartBrief | Apr 16, 2015

Magnesium intake linked to lower health risks, study says

DiabetesPro SmartBrief | Apr 16, 2015

Higher testicular cancer risk associated with muscle-building supplements

DiabetesPro SmartBrief | Apr 15, 2015

Study links foods containing nickel to obesity

DiabetesPro SmartBrief | Apr 15, 2015


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


DiabetesPro Career Center

DiabetesPro SmartBrief | Apr 20, 2015

Focus on Fellows – Fostering Diabetes Translational Physicians and Researchers

DiabetesPro SmartBrief | Apr 20, 2015

Standards of Medical Care in Diabetes: Abridged for Primary Care Providers – Now available

DiabetesPro SmartBrief | Apr 17, 2015

Free continuing education opportunity – Advocating on Behalf of the Student with Diabetes

DiabetesPro SmartBrief | Apr 16, 2015

Free-of-Charge Webcasts from the 62nd Annual Postgraduate Course -- Now available with CME/CE credits!

DiabetesPro SmartBrief | Apr 15, 2015




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.